Differential Roles of Fibroblast Growth Factor Receptors (FGFR) 1, 2 and 3 in the Regulation of S115 Breast Cancer Cell Growth

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Tarkkonen, Kati M ^a   Nilsson, Emeli M ^b   Kähkönen, Tiina E ^a,f   Dey, Julien H ^e   Heikkilä, Jari E ^c   Tuomela, Johanna M ^a,d   Liu, Qing ^b   Hynes, Nancy E ^e   Härkönen, Pirkko L ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b LUND UNIVERSITY   (Sweden)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d Pharmatest Services Ltd   (Finland)

^e FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^f Drug Discovery Section   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; BETA GALACTOSIDASE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENE TRANSFER; GROWTH REGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTOR 8; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; PYRIMIDINES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 84869787808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049970     Document Type: Article

References (55)

1. Ornitz DM, Itoh N, (2001) Fibroblast growth factors. Genome Biol 2(3): REVIEWS3005.
2. Goldfarb M, (1996) Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7(4): 311-325.
3. Eswarakumar VP, Lax I, Schlessinger J, (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2): 139-149.
4. Dailey L, Ambrosetti D, Mansukhani A, Basilico C, (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16(2): 233-247.
5. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, et al. (1991) BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6(4): 659-663.
6. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, et al. (1995) Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61(2): 170-176.
7. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, et al. (1993) Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54(3): 378-382.
8. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7): 870-874.
9. Dorkin TJ, Robinson MC, Marsh C, Bjartell A, Neal DE, et al. (1999) FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene 18(17): 2755-2761.
10. Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, et al. (2003) FGF8 isoform b expression in human prostate cancer. Br J Cancer 88(9): 1432-1438.
11. Tanaka A, Kamiakito T, Takayashiki N, Sakurai S, Saito K, (2002) Fibroblast growth factor 8 expression in breast carcinoma: Associations with androgen receptor and prostate-specific antigen expressions. Virchows Arch 441(4): 380-384.
12. Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, et al. (2001) Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer. Lab Invest 81(6): 815-826.
13. Mattila MM, Harkonen PL, (2007) Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. Cytokine Growth Factor Rev 18(3-4): 257-266.
14. Nilsson EM, Brokken LJ, Harkonen PL, (2009) Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death. Exp Cell Res 316(5): 800-12.
15. Mattila MM, Ruohola JK, Valve EM, Tasanen MJ, Seppanen JA, et al. (2001) FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 20(22): 2791-2804.
16. Hynes NE, Dey JH, (2010) Potential for targeting the fibroblast growth factor receptors in breast cancer. Cancer Res 70(13): 5199-202.
17. Turner N, Grose R, (2010) Fibroblast growth factor signalling: From development to cancer. Nat Rev Cancer 10(2): 116-129.
18. Mott NN, Chung WC, Tsai PS, Pak TR, (2010) Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines. PLoS One 5(4): e10143.
19. Ruohola JK, Valve EM, Vainikka S, Alitalo K, Harkonen PL, (1995) Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells. Endocrinology 136(5): 2179-2188.
20. Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacca M, et al. (2011) Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 30(41): 4231-4242.
21. Kanai M, Tashiro E, Maruki H, Minato Y, Imoto M, (2009) Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1. Gene 438(1-2): 49-56.
22. Nilsson EM, Brokken LJ, Narvi E, Kallio MJ, Harkonen PL, (2012) Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells. Mol Cell Endocrinol 358(1): 104-115.
23. Seyed M, Dimario JX, (2007) Sp1 is required for transcriptional activation of the fibroblast growth factor receptor 1 gene in neonatal cardiomyocytes. Gene 400(1-2): 150-157.
24. Tashiro E, Maruki H, Minato Y, Doki Y, Weinstein IB, et al. (2003) Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. Cancer Res 63(2): 424-431.
25. Koziczak M, Holbro T, Hynes NE, (2004) Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 23(20): 3501-3508.
26. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, et al. (1997) Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups. Cancer Res 57(19): 4360-4367.
27. Elbauomy Elsheikh S, Green AR, Lambros MB, Turner NC, Grainge MJ, et al. (2007) FGFR1 amplification in breast carcinomas: A chromogenic in situ hybridisation analysis. Breast Cancer Res 9(2): R23.
28. Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, et al. (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3(12): 655-667.
29. Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, et al. (2004) Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 64(1): 40-47.
30. Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, et al. (2008) Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res 68(17): 7165-7175.
31. Turner N, Pearson A, Sharpe R, Lambros M, Geyer F, et al. (2010) FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res 70(5): 2085-2094.
32. Katoh M, (2009) FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies. J Invest Dermatol 129(8): 1861-1867.
33. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148): 1087-1093.
34. Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, et al. (2010) Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene.
35. Yasumoto H, Matsubara A, Mutaguchi K, Usui T, McKeehan WL, (2004) Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells. Prostate 61(3): 236-242.
36. Jin C, McKeehan K, Guo W, Jauma S, Ittmann MM, et al. (2003) Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Cancer Res 63(24): 8784-8790.
37. Freeman KW, Gangula RD, Welm BE, Ozen M, Foster BA, et al. (2003) Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer Res 63(19): 6237-6243.
38. Xian W, Schwertfeger KL, Rosen JM, (2007) Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol Endocrinol 21(4): 987-1000.
39. Ruohola JK, Viitanen TP, Valve EM, Seppanen JA, Loponen NT, et al. (2001) Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res 61(10): 4229-4237.
40. Francavilla C, Maddaluno L, Cavallaro U, (2009) The functional role of cell adhesion molecules in tumor angiogenesis. Semin Cancer Biol 19(5): 298-309.
41. Murakami M, Elfenbein A, Simons M, (2008) Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc Res 78(2): 223-231.
42. Francavilla C, Cattaneo P, Berezin V, Bock E, Ami D, et al. (2009) The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J Cell Biol 187(7): 1101-1116.
43. Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, et al. (2010) Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res 70(10): 4151-4162.
44. Tarkkonen K, Ruohola J, Harkonen P, (2010) Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells. Growth Factors 28(4): 256-67.
45. Dey JH (2010) Investigating the contribution of FGF receptors in breast tumorigenesis using models of mammary cancer. Doctoral Thesis. 10.5451/unibas-005213494. Available: edoc.unibas.ch via the Internet.
46. Tuittila MT, Santagati MG, Roytta M, Maatta JA, Hinkkanen AE, (2000) Replicase complex genes of semliki forest virus confer lethal neurovirulence. J Virol 74(10): 4579-4589.
47. Darbre PD, King RJ, (1988) Steroid hormone regulation of cultured breast cancer cells. Cancer Treat Res 40: 307-341.
48. Harkonen PL, Laaksonen EI, Valve EM, Solic N, Darbre PD, (1990) Temperature-sensitive mutants for steroid-sensitive growth of S115 mouse mammary tumor cells. Exp Cell Res 186(2): 288-298.
49. Mattila MM, Ruohola JK, Valve EM, Tasanen MJ, Seppanen JA, et al. (2001) FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 20(22): 2791-2804.
50. Osborne CK, Hobbs K, Trent JM, (1987) Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat 9(2): 111-121.
51. Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL, (1993) Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85(17): 1412-1418.
52. Kallio A, Guo T, Lamminen E, Seppanen J, Kangas L, et al. (2008) Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Mol Cell Endocrinol 289(1-2): 38-48.
53. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4): 402-408.
54. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, et al. (2007) Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282(37): 26687-26695.
55. Kettunen P, Karavanova I, Thesleff I, (1998) Responsiveness of developing dental tissues to fibroblast growth factors: Expression of splicing alternatives of FGFR1,-2,-3, and of FGFR4; and stimulation of cell proliferation by FGF-2,-4,-8, and-9. Dev Genet 22(4): 374-385.